Evidence map›Paper›PMID 35426590›Full record

ArticleAnnals of surgical oncology2022

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).

Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, Charlotte Ariyan, Paolo A Ascierto, Salvatore V M A Asero, Christian U Blank, Matthew S Block, Genevieve M Boland, Corrado Caraco and 32 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Guideline
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 8 countries.

Alexander C J van AkkooiNetherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. a.v.akkooi@nki.nl.
Tina J HiekenMayo Clinic, Rochester, MN, USA.
Elizabeth M BurtonThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Charlotte AriyanMemorial Sloan Kettering Cancer Center, New York City, NY, USA.
Paolo A AsciertoIstituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Salvatore V M A AseroAzienda di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy.
Christian U BlankNetherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Matthew S BlockMayo Clinic, Rochester, MN, USA.
Genevieve M BolandMassachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7522-6173
Corrado CaracoIstituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Sydney ChngMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
B Scott DavidsonNorthside Hospital Cancer Institute, Atlanta, GA, USA.
Joao Pedreira Duprat NetoAC Camargo Cancer Center, São Paulo, Brazil.
Mark B FariesThe Angeles Clinic, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Jeffrey E GershenwaldThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dirk J GrunhagenErasmus MC - Cancer Institute, Rotterdam, The Netherlands.
David E GyorkiPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Dale HanOregon Health and Science University, Portland, Oregon, USA.
Andrew J HayesRoyal Marsden NHS Foundation Trust, London, UK.
Winan J van HoudtNetherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Giorgos C KarakousisHospital of the University of Pennsylvania, Philadelphia, PA, USA.
Willem M C KlopNetherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Georgina V LongMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Michael C LoweWinship Cancer Institute, Emory University, Atlanta, GA, USA.
Alexander M MenziesMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Roger Olofsson BaggeSahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Thomas E PenningtonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Piotr RutkowskiDepartment of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Robyn P M SawMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Kerwin F ShannonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Vernon K SondakMoffitt Cancer Center, Tampa, Florida, USA.
Hussein TawbiThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alessandro A E TestoriSkin Oncology Division, Image Regenerative Clinic, Milan, Italy.
Mike T TetzlaffUniversity of California San Francisco (UCSF), San Francisco, CA, USA.
John F ThompsonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Jonathan S ZagerMoffitt Cancer Center, Tampa, Florida, USA.
Charlotte L ZuurNetherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Jennifer A WargoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Andrew J SpillaneMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Merrick I RossThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
International Neoadjuvant Melanoma Consortium (INMC)
The University of Sydney · AUThe University of Texas MD Anderson Cancer Center · USThe Netherlands Cancer Institute · NLIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITMayo Clinic in Arizona · USMoffitt Cancer Center · USAC Camargo Hospital · BRAzienda di Rilievo Nazionale ed Alta Specializzazione · ITCedars-Sinai Medical Center · USEmory University · USErasmus MC Cancer Institute · NLHospital of the University of Pennsylvania · USLeiden University Medical Center · NLMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · USNorthside Hospital · USOregon Health & Science University · USPeter MacCallum Cancer Centre · AURoyal Marsden NHS Foundation Trust · GBSahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35426590
OpenAlexW4224105116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.